Albion Financial Group Pfizer Inc Transaction History

Albion Financial Group

$1.29 Billion
Q1 2024

A detailed history of Albion Financial Group transactions in Pfizer Inc stock. As of the latest transaction made, Albion Financial Group holds 1,512 shares of PFE stock, worth $41,882. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,512

Previous 1,543 2.01%

Holding current value

$41,882

Previous $44,000 6.82%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 19, 2024	SELL	$25.89 - $29.73 $802 - $921	-31 Reduced 2.01%	1,512 $41,000
Q4 2023 Jan 26, 2024	BUY	$26.13 - $33.94 $810 - $1,052	31 Added 2.05%	1,543 $44,000
Q3 2023 Nov 01, 2023	SELL	$32.09 - $37.51 $352 - $412	-11 Reduced 0.72%	1,512 $50,000
Q2 2023 Jul 25, 2023	BUY	$36.12 - $41.79 $397 - $459	11 Added 0.73%	1,523 $55,000
Q1 2023 Apr 18, 2023	SELL	$39.39 - $51.28 $30,724 - $39,998	-780 Reduced 34.03%	1,512 $61,000

Q4 2022 Feb 03, 2023	BUY	$41.75 - $54.5 $208 - $272	5 Added 0.22%	2,292 $117,000
Q3 2022 Oct 27, 2022	BUY	$43.76 - $53.42 $306 - $373	7 Added 0.31%	2,287 $100,000
Q2 2022 Jul 29, 2022	SELL	$46.53 - $55.17 $74,168 - $87,940	-1,594 Reduced 41.15%	2,280 $120,000
Q1 2022 May 09, 2022	SELL	$45.75 - $56.69 $10,202 - $12,641	-223 Reduced 5.44%	3,874 $201,000
Q4 2021 Feb 15, 2022	BUY	$41.32 - $61.25 $1,900 - $2,817	46 Added 1.14%	4,097 $242,000
Q3 2021 Oct 19, 2021	SELL	$39.25 - $50.42 $4,082 - $5,243	-104 Reduced 2.5%	4,051 $174,000
Q2 2021 Aug 12, 2021	SELL	$35.91 - $40.68 $31,421 - $35,595	-875 Reduced 17.4%	4,155 $163,000
Q4 2020 Feb 19, 2021	SELL	$33.47 - $42.56 $26,508 - $33,707	-792 Reduced 13.6%	5,030 $185,000
Q3 2020 Nov 13, 2020	BUY	$31.75 - $37.25 $184,848 - $216,869	5,822 New	5,822 $214,000
Q1 2020 May 08, 2020	SELL	$27.03 - $38.62 $168,450 - $240,679	-6,232 Closed	0 $0
Q4 2019 Jan 31, 2020	SELL	$32.92 - $37.36 $49,215 - $55,853	-1,495 Reduced 19.35%	6,232 $244,000
Q3 2019 Nov 08, 2019	SELL	$32.49 - $42.13 $476,530 - $617,920	-14,667 Reduced 65.5%	7,727 $278,000
Q2 2019 Aug 08, 2019	SELL	$36.98 - $41.52 $20,708 - $23,251	-560 Reduced 2.44%	22,394 $970,000
Q1 2019 May 14, 2019	SELL	$37.5 - $41.2 $2,625 - $2,884	-70 Reduced 0.3%	22,954 $975,000
Q3 2018 Nov 20, 2018	SELL	$34.47 - $41.81 $31,023 - $37,629	-900 Reduced 3.76%	23,024 $1.02 Million
Q1 2018 Apr 17, 2018	SELL	$31.91 - $37.02 $31,910 - $37,020	-1,000 Reduced 4.01%	23,924 $849,000
Q4 2017 Feb 22, 2018	SELL	$33.26 - $35.29 $17,128 - $18,174	-515 Reduced 2.02%	24,924 $903,000
Q3 2017 Nov 09, 2017	SELL	$31.0 - $34.15 $21,483 - $23,665	-693 Reduced 2.65%	25,439 $908,000
Q2 2017 Aug 15, 2017	BUY	N/A	26,132	26,132 $878,000

Others Institutions Holding PFE

# of Institutions

3,158

Shares Held

3.68B

Call Options Held

67.4M

Put Options Held

113M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $155B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Albion Financial Group , based on Form 13F filings with the SEC.

News

Stay updated on Albion Financial Group with notifications on news.

Account

Albion Financial Group Pfizer Inc Transaction History